Clinical Trial Update: [68Ga]Ga-FAPI-46 PET/CT in Ovarian Cancer [Phase 2]

View source ↗

Summary

This is an ongoing Phase 2 clinical trial evaluating [68Ga]Ga-FAPI-46 PET/CT in ovarian cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• [68Ga]Ga-FAPI-46 PET/CT radiotracer (Ga-FAPI-46 radiotracer)

Snippet

Sponsor: Aalborg University Hospital | Conditions: Ovarian Cancer | Phase 2 | Status: RECRUITING